AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank93
3Y CAGR+29.7%
5Y CAGR+12.0%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+29.7%/yr
vs -3.0%/yr prior
5Y CAGR
+12.0%/yr
Recent acceleration
Acceleration
+32.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$15.83B+30.7%
2024$12.11B+76.8%
2023$6.85B-5.6%
2022$7.26B-63.9%
2021$20.10B+123.5%
2020$8.99B+23.7%
2019$7.27B-11.2%
2018$8.18B+7.7%
2017$7.60B+5.4%
2016$7.21B-